Technology market

Global Bioprocess Technology Market Report – Size and Growth at a CAGR of ~15% by 2028, Forecast and Analysis by ZMR

Zion Market Research

The global bioprocess technology market is expected to reach US$79 billion by 2028, growing at a CAGR of 15% between 2022 and 2028.

Global bioprocess technology was valued at US$18 billion in 2021 and is expected to generate revenue of US$79 billion by 2028 while growing at a CAGR of 15% during the forecast period.

— Sion Market Research

DEERFIELD BEACH, FLORIDA, USA, September 1, 2022 / — The Global Bioprocess Technology Market is expected to grow at a CAGR of 15% over the forecast period. The global market generated over US$18 billion in revenue in 2021 and is expected to reach a market value of US$79 billion by 2028.

The study also provides a summary of many other important areas, such as the financial performance of key companies, a SWOT analysis, a product portfolio and the most recent changes in strategic planning.

Get a free PDF sample at

Market growth

The Global bioprocess technology market is expected to register higher growth in the coming years due to the extensive use of these technologies in two of the fastest growing industries food and pharmaceuticals. Since bioprocessing is a natural and one of the safest means by which food manufacturers can make items like cheese, wine, beer, bread and yogurt which are staple foods in almost all forms of diet, bioprocessing technology has immense application in this sector. In the pharmaceutical sector, biomedical research and subsequent processes are used to pave the way for innovative pharmaceutical products that have huge implications on the healthcare sector. As the industry is facing immense pressure owing to higher demands, reduced delivery times and increased costs, the global market is receiving numerous contributions from key players to upgrade the bioprocess technologies that serve them. will ultimately help meet growing medical needs.

The growth of the global market can also be attributed to the growing demand for specialized and disease-focused treatments, which propels the need to invest in bioprocess therapies like cell therapy. The growing research on recombinant DNA technology, which makes extensive use of bioprocess technology, can also contribute to the expansion of the global market.

Key ideas:
A) According to the analysis shared by our research analyst, the global bioprocess technology market is expected to grow annually at a CAGR of around 15% over the forecast period (2022-2028).
B) In terms of revenue, the global Bioprocess Technology market size was valued at around USD 18 Billion in 2021 and is projected to reach USD 79 Billion by 2028. Due to various driving factors, the market is expected to grow at a significant rate.
C) Based on segmentation by type, cell culture segment is expected to show maximum market share in 2021
D) Based on application segmentation, Biopharma was the top revenue-generating category in 2021.
E) Based on region, North America was the top revenue generator in 2021.

Get more information before buying @:


Large-scale bioproduction is extremely labor-intensive, capital-intensive, and time-consuming compared to non-bioprocess technologies. This is due to the multiple variables involved as well as many individual processes. Protein purification is one of the most expensive expenses of all bioprocess production and accounts for over 50% of the total cost, making it difficult for small manufacturers to use the technology. In emerging economies, the cost becomes even higher as the majority of bioprocess technology has to be imported, creating difficult situations for global market expansion.

Regional analysis

The global bioprocess technology market was dominated by North America in 2021 and is expected to follow the same trend due to increasing geriatric population and the presence of numerous bioprocess technology manufacturers in regions like the United States and Canada. North America held more than 85% of global market revenue in 2021 due to rising living standards and corresponding disposable income of the general population, encouraging them to spend on medical care. The regional growth can also be attributed to the advanced economy and increasing funding for research activities.

Europe holds a considerable share of the global market, mainly due to the constant expansion of the pharmaceutical sector and the growing demand for monoclonal antibodies, biosimilars and recombinant proteins. The region can also experience strong growth due to excellent medical care reimbursement policies.

To read the full report, visit

A) In September 2021, a one-of-a-kind toilet paper and paper towel was launched by Cascades in the United States and Canada. Bathroom products will be made from 100% recycled plastic packaging. Cascades is a leader in the circular economy and, with the launch of new packaging systems, it intends to reduce the environmental impacts of its operations. The launch was accompanied by excellent promotional campaigns.
B) In November 2020, LTC Group was acquired by Accrol. LTC Group manufactures fabric converters. With this acquisition, Accrol intends to scale up the business with high quality modern machinery assets that will facilitate day-to-day operations.

Get a free PDF sample at

Some Key Players of Global Bioprocess Technology Market are:

GE Healthcare (General Electric Company)
Thermo Fisher Scientific
IncSartorius AG
Eppendorf AG
Dickinson and company
Siemens Healthineers
Nova Biomedical
Advanced Instruments
F. Hoffmann-La Roche Ltd.
Danaher Corporation.

Get a free PDF sample at

This report segments the global bioprocess technology market into:

Global Bioprocess Technology Market: By Application

Specialty products
Help with environmental management
Industrial chemicals

Global Bioprocess Technology Market: By Type

Cell expansion
Cell culture
Cell line development
Flow cytometry
Virus Infiltration

Global Bioprocess Technology Market: By End User

Medical institutions
Laboratories and research centers

Related press release: industry-trends-share-growth-rate

Global Bioprocess Technology Market: Regional Analysis

North America
United States
Great Britain
The rest of Europe
Asia Pacific
South Korea
South East
Rest of Asia-Pacific
Latin America
Rest of Latin America
Middle East and Africa
South Africa
Rest of the Middle East and Africa

Contact us :

Rushikesh Dorge
Zion Market Research
+1 855-465-4651
[email protected]
Visit us on social media: